Carol Schafer is Director of INSMED Inc. Currently has a direct ownership of 58,259 shares of INSM, which is worth approximately $4.1 Million. The most recent transaction as insider was on May 13, 2024, when has been sold 13,162 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 58.3K
0% 3M change
29.19% 12M change
Total Value Held $4.1 Million

CAROL SCHAFER Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 13 2024
BUY
Grant, award, or other acquisition
-
13,162 Added 18.43%
58,259 Common Stock
May 11 2023
BUY
Grant, award, or other acquisition
-
13,192 Added 22.63%
45,097 Common Stock
May 11 2022
BUY
Grant, award, or other acquisition
-
14,645 Added 31.46%
31,905 Common Stock
May 12 2021
BUY
Grant, award, or other acquisition
-
7,558 Added 30.45%
17,260 Common Stock

Also insider at

IDRA
IDERA PHARMACEUTICALS, INC. Healthcare
FPRX
FIVE PRIME THERAPEUTICS, INC.
RPTX
Repare Therapeutics Inc. Healthcare
KURA
Kura Oncology, Inc. Healthcare
IMNM
Immunome Inc. Healthcare
CS

Carol Schafer

Director
Bridgewater, NJ

Track Institutional and Insider Activities on INSM

Follow INSMED Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INSM shares.

Notify only if

Insider Trading

Get notified when an Insmed Inc insider buys or sells INSM shares.

Notify only if

News

Receive news related to INSMED Inc

Track Activities on INSM